|
|
Article: Corgentech Raises $50 Million in Series C Financing; Fritz Buhler MD, Managing Partner at Bear Stearns Health Innoventures, LP, Appointed to Company's Board of Directors.
- Article from:
- PR Newswire
- Article date:
- July 16, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PALO ALTO, Calif. -- Corgentech, Inc., a privately-held biotechnology company, announced today that it raised $50 million through its recently completed Series C financing round, which was led by Bear Stearns Health Innoventures, L.P. Additional investors include JP Morgan Partners, HBM Bioventures LTD, Alta Partners, InterWest Partners, CDIB, Temasek, PRM Ventures and others. JPMorgan H&Q was the exclusive placement agent for the offering.
Net proceeds from this financing will be used for the Phase III clinical development of the Company's lead product candidate for prevention of coronary and peripheral arterial bypass graft failure, continued development of ...